Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AZD-1656 by Conduit Pharmaceuticals for Uveitis: Likelihood of Approval
AZD-1656 is under clinical development by Conduit Pharmaceuticals and currently in Phase I for Uveitis. According to GlobalData, Phase I...